Designing next generation of photosensitizers: recent advances in NIR-II triggered organic photodynamic nanomedicines
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Hybrid graphene-gold nanoparticle-based nucleic acid conjugates for cancer-specific multimodal imaging and combined therapeutics
2. Structurally simple osmium(II) polypyridyl complexes as photosensitizers for photodynamic therapy in the near infrared10.1002/anie.202218347 ↗
3. Intraligand excited states turn a ruthenium oligothiophene complex into a light-triggered ubertoxin with anticancer effects in extreme hypoxia10.1021/jacs.2c02475 ↗
4. A tumor-specific platform of peroxynitrite triggering ferroptosis of cancer cells10.1002/adfm.202208105 ↗
5. A facile, protein-derived supramolecular theranostic strategy for multimodal-imaging-guided photodynamic and photothermal immunotherapy in vivo10.1002/adma.202109111 ↗
6. Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway10.1038/s41467-023-40826-5 ↗
7. Cationic telluroviologen derivatives as type-I photosensitizers for tumor photodynamic theranostics10.1002/agt2.298 ↗
8. Tumor starvation induced spatiotemporal control over chemotherapy for synergistic therapy10.1002/smll.201803602 ↗
9. Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy10.1016/j.dyepig.2022.110478 ↗
10. Rational design of polymethine dyes with NIR-II emission and high photothermal conversion efficiency for multimodal-imaging-guided photo-immunotherapy10.1002/adma.202210179 ↗
11. Dual-responsive triple-synergistic Fe-MOF for tumor theranostics10.1021/acsnano.2c10310 ↗
12. Heavy atom-free semiconducting polymer with high singlet oxygen quantum yield for prostate cancer synergistic phototherapy10.1039/C9QM00158A ↗
13. Single-component nanoagents with large stokes shift for high-effect phototheranostics10.1016/j.dyepig.2023.111494 ↗
14. Enzyme-responsive double-locked photodynamic molecular beacon for targeted photodynamic anticancer therapy10.1021/jacs.2c13732 ↗
15. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine10.1021/acsnano.3c00891 ↗
16. Overcoming the challenges of infrared photosensitizers in photodynamic therapy: the making of redaporfin10.1039/D3CC02283H ↗
17. From low to No O2-dependent hypoxia photodynamic therapy (hPDT): a new perspective10.1021/acs.accounts.2c00531 ↗
18. Photodynamic therapeutic effect of nanostructured metal sulfide photosensitizers on cancer treatment10.1186/s11671-022-03674-8 ↗
19. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
20. Three birds with one stone: acceptor engineering of hemicyanine dye with NIR-II emission for synergistic photodynamic and photothermal anticancer therapy10.1002/smll.202204851 ↗
21. Multifunctional MnO2/Ag3SbS3 nanotheranostic agent for single-laser-triggered tumor synergistic therapy in the NIR-II biowindow10.1021/acsami.1c21752 ↗
22. Recent advances in the design and applications of near-infrared II responsive small molecule phototherapeutic agents10.1016/j.ccr.2024.215677 ↗
23. A versatile 980 nm excitable small molecule for short-wave infrared fluorescence imaging guided type-I photodynamic/photothermal therapy10.1016/j.snb.2025.137807 ↗
24. Confined semiconducting polymers with boosted NIR light-triggered H2O2 production for hypoxia-tolerant persistent photodynamic therapy10.1039/D4SC01609B ↗
25. FRET-engineering of organic nanoparticles for photoacoustic imaging-guided photodynamic and augmented photothermal therapy10.1016/j.snb.2023.135091 ↗
26. A “dual-source, dual-activation” strategy for an NIR-II window theranostic nanosystem enabling optimal photothermal-ion combination therapy10.1002/smll.202201179 ↗
27. Maximum emission peak over 1500 nm of organic assembly for blood-brain barrier-crossing NIR-IIb phototheranostics of orthotopic glioblastoma
28. Metal-coordinated NIR-II nanoadjuvants with nanobody conjugation for potentiating immunotherapy by tumor metabolism reprogramming10.1002/advs.202404886 ↗
29. NIR-II light activated photosensitizer with aggregation-induced emission for precise and efficient two-photon photodynamic cancer cell ablation
30. Mitochondrion-anchored photosensitizer with near infrared-I aggregation-induced emission for near infrared-II two-photon photodynamic therapy10.1002/adhm.202101056 ↗
31. Self-assembled organic nanomedicine enables ultrastable photo-to-heat converting theranostics in the second near-infrared biowindow10.1038/s41467-020-20566-6 ↗
32. Second near-infrared photothermal materials for combinational nanotheranostics10.1039/D0CS00664E ↗
33. A borondifluoride-complex-based photothermal agent with an 80 % photothermal conversion efficiency for photothermal therapy in the NIR-II window10.1002/anie.202107836 ↗
34. Conjugated-polymer-based nanomaterials for photothermal therapy10.1021/acsapm.0c00680 ↗
35. Recent advances in the design of organic photothermal agents for cancer treatment: a review10.1016/j.ccr.2024.215719 ↗
36. Rational design of biomaterials to potentiate cancer thermal therapy10.1021/acs.chemrev.2c00822 ↗
37. Manipulating host-guest charge transfer of a water-soluble double-cavity cyclophane for NIR-II photothermal therapy
38. Inhibiting osteolytic breast cancer bone metastasis by bone-targeted nanoagent via remodeling the bone tumor microenvironment combined with NIR-II photothermal therapy10.1002/smll.202301003 ↗
39. Synthesis of germanium/germanium phosphide in-plane heterostructure with efficient photothermal and enhanced photodynamic effects in the second near-infrared biowindow10.1016/j.jcis.2023.08.137 ↗
40. Effective nanocomposite based on Bi2MoO6/MoS2/AuNRs for NIR-II light-boosted photodynamic/chemodynamic therapy10.1021/acs.langmuir.3c00372 ↗
41. Molecular oligomerization and donor engineering strategies for achieving superior NIR-II fluorescence imaging and thermotherapy under 1064 nm laser irradiation
42. Photoactive oligomer with D–D′–A–D′–D′′–D′–A–D′–D scaffold for high-efficiency NIR-II phototheranostics10.1039/D3CC02199H ↗
43. Simple preparation of near-infrared-II organic small molecule-based phototheranostics by manipulation of the electron-donating unit10.6023/A22060267 ↗
44. Organic semiconducting luminophores for near-infrared afterglow, chemiluminescence, and bioluminescence imaging
45. Near-infrared-II triggered inorganic photodynamic nanomedicines for deep-tissue therapy10.1016/j.jmst.2024.07.002 ↗
46. Beyond traditional light: NIR-II light-activated photosensitizers for cancer therapy10.1039/D3TB00668A ↗
47. Bright near-infrared π-conjugated oligomer nanoparticles for deep-brain three-photon microscopy excited at the 1700 nm window in vivo10.1021/acsnano.2c03813 ↗
48. Modulating aggregation and deaggregation based on assembling strategy to switch on NIR-II light-excited fluorescence for self-reporting viability of eliminating cancer cell10.1021/acs.analchem.4c03788 ↗
49. Molecular tailoring based on forster resonance energy transfer for initiating two-photon theranostics with amplified reactive oxygen species10.1021/acs.analchem.2c03408 ↗
50. A RNA-targeted two-photon bioprobe with high selective permeability into nuclear pore complexes for dynamically tracking the autophagy process among multi-organelles10.1021/acs.analchem.9b03009 ↗
51. AIE-based theranostic agent: in situ tracking mitophagy prior to late apoptosis to guide the photodynamic therapy10.1021/acsami.9b15577 ↗
52. Coumarin-based fluorescent probes for super-resolution and dynamic tracking of lipid droplets10.1021/acs.analchem.8b04079 ↗
53. Facile protein assembly activating three-photon activity: a zig-zag lift modulated by the “odd-even” effect of alkyl chains10.1007/s40843-022-2368-3 ↗
54. NIR-II light-activated two-photon squaric acid dye with type I photodynamics for antitumor therapy10.1515/nanoph-2022-0482 ↗
55. An NIR-II two-photon excitable AIE photosensitizer for precise and efficient treatment of orthotopic small-size glioblastoma
56. GSH-activatable copper-elsinochrome off-on photosensitizer for combined specific NIR-II two-photon photodynamic/chemodynamic therapy
57. Tailored engineering of novel xanthonium polymethine dyes for synergetic PDT and PTT triggered by 1064 nm laser toward deep-seated tumors10.1002/smll.202100398 ↗
58. Development of a novel anti-tumor theranostic platform: a near-infrared molecular upconversion sensitizer for deep-seated cancer photodynamic therapy10.1039/C9SC04034J ↗
59. An NIR-II excitable AIE small molecule with multimodal phototheranostic features for orthotopic breast cancer treatment
60. High-efficiency organic semiconducting small molecule for deep-tissue phototheranostics: single 1064 nm laser triggered NIR-IIb fluorescence imaging guided type-I photodynamic/photothermal combination therapy
61. Achieving efficient NIR-II type-I photosensitizers for photodynamic/photothermal therapy upon regulating chalcogen elements10.1002/adma.202108146 ↗
62. Co-delivery of NIR-II semiconducting polymer and pH-sensitive doxorubicin-conjugated prodrug for photothermal/chemotherapy10.1016/j.actbio.2021.10.009 ↗
63. Semiconducting polymer-based nanoparticles for photothermal therapy at the second near-infrared window10.1039/C8CC07583B ↗
64. NIR-II light accelerated prodrug reduction of Pt(IV)-incorporating pseudo semiconducting polymers for robust degradation and maximized photothermal/chemo-immunotherapy10.1002/adma.202300048 ↗
65. Near-infrared-II photoacoustic imaging and photo-triggered synergistic treatment of thrombosis via fibrin-specific homopolymer nanoparticles10.1038/s41467-023-42691-8 ↗
66. Stimuli-responsive organic near-infrared photoacoustic probes10.1002/adfm.202300023 ↗
67. Targeted contrast agents and activatable probes for photoacoustic imaging of cancer10.1039/D0CS00771D ↗
68. Quinoxalineimide-based semiconducting polymer nanoparticles as an effective phototheranostic for the second near-infrared fluorescence imaging and photothermal therapy10.1021/acsami.3c06853 ↗
69. Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics10.1016/j.addr.2023.114821 ↗
70. Simultaneous enhancement of the long-wavelength NIR-II brightness and photothermal performance of semiconducting polymer nanoparticles10.1021/acsami.1c20722 ↗
71. NIR-II excitable semiconducting polymers with AIE characteristics for fluorescence-photoacoustic imaging-guided synergistic phototherapy
72. Enhancing near-infrared II photodynamic therapy with nitric oxide for eradicating multidrug-resistant biofilms in deep tissues